<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=545163149217500&amp;ev=PageView&amp;noscript=1">
Contact a product expert for TherOx SSO2 Threrapy

SSO2 Therapy is the only FDA-approved treatment to reduce infarct size following STEMI. SSO2 utilizes proprietary technology to deliver hyperoxemic blood locally to the patient's coronary artery following primary PCI.

Please fill out the form and a product expert on SSO2 Therapy will be in touch to address your questions.

 

Please fill out the following form and a product expert on SSO2 Therapy will be in touch.